UK HAIs (hospital acquired infection): a £1 billion challenge
This article was originally published in Clinica
This week saw a spate of reports on the UK's hospital acquired infection (HAI) situation. The problem - which already costs the NHS an estimated £1bn ($1.86bn) a year - is being billed as the UK's greatest healthcare challenge, affecting over 100,000 patients and causing some 5,000 deaths. These 2000 figures are said to be "the best estimate available", according to the National Audit Office, in its four-year review of the situation. The NAO report criticises the failure to establish a comprehensive mandatory surveillance scheme, despite plans to improve HAI monitoring (through the NINSS set up in 1996) with orthopaedic surgical site infection, bacteraemia and post-discharge surveillance.
You may also be interested in...
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.